Andy, Author at RareCan

Andy Hall

Chief Scientific Officer

Andy retired from Newcastle University in 2016. After qualifying in medicine, he specialised in haematology before moving to laboratory-based research in childhood leukaemia. He was the Director of the Northern Institute for Cancer Research and has served as a non-executive director for the Human Tissue Authority. He is currently on leave of absence as the chair of an NHS Research Ethics Committee.

Andy is also our Data Protection Officer and can be emailed at dpo@rarecan.com for queries related to our privacy policy.

Videos featuring Andy

Blog posts by Andy

PARP inhibitors may prevent tumours in BRCA positive cancers

August 22, 2022

18th August 2022 – Rare Cancer in the News Professor Andy Hall looks at some recent news about the impact PARP inhibitors could have on

Andy Hall

Chief Scientific Officer

Videos featuring Andy

Blog posts by Andy

PARP inhibitors may prevent tumours in BRCA positive cancers

Index

Resources

Social